ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2016

May 27, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2016-05-26

Reporting Person: Clendeninn Neil James (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-26	Stock Option (right to buy)	$1.00	A	22500	Acquired	2026-05-26	Common Stock (22500)	Direct

Footnotes

F1: The options vest 100% on the earlier of May 26, 2017 or the date immediately prior to the issuer's next annual meeting of stockholders.